Publication related to RSI or an RSI staff member
Association of allergic diseases and epilepsy with risk of glioma, meningioma and acoustic neuroma: results from the INTERPHONE international case-control study.
Authors
- Schlehofer, Brigitte, Schlehofer B, Leimen, Germany (retired); formerly: Unit of Environmental Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Blettner, Maria, Blettner M, Institute of Medical Biostatistics, Epidemiology and Informatics, University of Mainz, Mainz, Germany.
- Moissonnier, Monika, Moissonnier M, International Agency for Research On Cancer (IARC/WHO), Environment and Lifestyle Epidemiology Branch, Lyon, France.
- Deltour, Isabelle, Deltour I, International Agency for Research On Cancer (IARC/WHO), Environment and Lifestyle Epidemiology Branch, Lyon, France.
- Giles, Graham G, Giles GG, Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
- Armstrong, Bruce, Armstrong B, School of Public Health, University of Sydney, Sydney, Australia.
- Siemiatycki, Jack, Siemiatycki J, University of Montreal, Montreal, Canada.
- Parent, Marie-Elise, Parent ME, Institut National de La Recherche Scientifique (INRS), Laval, Canada.
- Krewski, Daniel, Krewski D, McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Canada.
- Johansen, Christoffer, Johansen C, Center for Surgery and Cancer, Rigshospitalet, Copenhagen, Denmark.
- Auvinen, Anssi, Auvinen A, Faculty of Social Sciences, Tampere University, Tampere, Finland.; STUK Radiation and Nuclear Safety Authority, Environmental Radiation Surveillance, Helsinki, Finland.
- Lahkola, Anna, Lahkola A, STUK Radiation and Nuclear Safety Authority, Environmental Radiation Surveillance, Helsinki, Finland.
- Hours, Martine, Hours M, Université Lyon 1, IFSTTAR, UMRESTTE, Bron, France.
- Berg-Beckhoff, Gabriele, Berg-Beckhoff G, Unit for Health Promotion Research, Department of Public Health, and Hospital South West Jutland Esbjerg, University of Southern Denmark, Odense, Denmark.
- Sadetzki, Siegal, Sadetzki S, Cancer & Radiation Epidemiology Unit, Gertner Institute for Epidemiology & Health Policy Research, Sheba Medical Center, Tel-Hashomer, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Ministry of Health, Jerusalem, Israel.
- Lagorio, Susanna, Lagorio S, Department of Oncology and Molecular Medicine, Istituto Superiore Di Sanità , Rome, Italy.
- Takebayashi, Toru, Takebayashi T, Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan.
- Yamaguchi, Naohito, Yamaguchi N, Department of Public Health, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
- Woodward, Alistair, Woodward A, School of Population Health, University of Auckland, Auckland, New Zealand.
- Cook, Angus, Cook A, Population and Global Health, The University of Western Australia, Perth, WA, Australia.
- Tynes, Tore, Tynes T, National Institute of Occupational Health, Oslo, Norway.
- Klaboe, Lars, Klaboe L, Norwegian Radiation Protection Authority, Østerås; The Cancer Registry of Norway, Oslo, Norway.
- Feychting, Maria, Feychting M, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
- Feltbower, Richard, Feltbower R, School of Medicine, University of Leeds, Leeds, UK.
- Swerdlow, Anthony, Swerdlow A, Institute of Cancer Research, Sutton, UK.
- Schoemaker, Minouk, Schoemaker M, Institute of Cancer Research, Sutton, UK.
- Cardis, Elisabeth, Cardis E, Barcelona Institute of Global Health (ISGlobal), Barcelona, Spain.; University Pompeu Fabra, Barcelona, Spain.; CIBER Epidemiologia Y Salud Pública, Madrid, Spain.
- Schuz, Joachim, Schuz J, International Agency for Research On Cancer (IARC/WHO), Environment and Lifestyle Epidemiology Branch, Lyon, France. schuzj@iarc.fr.
YEAR OF PUBLICATION: 2022
SOURCE: Eur J Epidemiol. 2022 May;37(5):503-512. doi: 10.1007/s10654-022-00843-y. Epub 2022 Feb 3.
JOURNAL TITLE ABBREVIATION: Eur J Epidemiol
JOURNAL TITLE: European journal of epidemiology
ISSN: 1573-7284 (Electronic) 0393-2990 (Linking)
VOLUME: 37
ISSUE: 5
PAGES: 503-512
PLACE OF PUBLICATION: Netherlands
ABSTRACT:
We investigated the association of allergic diseases and epilepsy with risk of brain tumours, in Interphone, a 13-country case-control study. Data were obtained from 2693 glioma cases, 2396 meningioma cases, and 1102 acoustic neuroma cases and their 6321 controls. Conditional logistic regression models were used to estimate pooled odds ratios (ORs) and their respective 95% confidence intervals (CIs), adjusted for education and time at interview. Reduced ORs were observed for glioma in relation to physician-diagnosed asthma (OR = 0.73; CI 0.58-0.92), hay fever (OR 0.72; CI 0.61-0.86), and eczema (OR 0.78, CI 0.64-0.94), but not for meningioma or acoustic neuroma. Previous diagnosis of epilepsy was associated with an increased OR for glioma (2.94; CI 1.87-4.63) and for meningioma (2.12; CI 1.27-3.56), but not for acoustic neuroma. This large-scale case-control study adds to the growing evidence that people with allergies have a lower risk of developing glioma, but not meningioma or acoustic neuroma. It also supports clinical observations of epilepsy prior to the diagnosis of glioma and meningioma.
We investigated the association of allergic diseases and epilepsy with risk of brain tumours, in Interphone, a 13-country case-control study. Data were obtained from 2693 glioma cases, 2396 meningioma cases, and 1102 acoustic neuroma cases and their 6321 controls. Conditional logistic regression models were used to estimate pooled odds ratios (ORs) and their respective 95% confidence intervals (CIs), adjusted for education and time at interview. Reduced ORs were observed for glioma in relation to physician-diagnosed asthma (OR = 0.73; CI 0.58-0.92), hay fever (OR 0.72; CI 0.61-0.86), and eczema (OR 0.78, CI 0.64-0.94), but not for meningioma or acoustic neuroma. Previous diagnosis of epilepsy was associated with an increased OR for glioma (2.94; CI 1.87-4.63) and for meningioma (2.12; CI 1.27-3.56), but not for acoustic neuroma. This large-scale case-control study adds to the growing evidence that people with allergies have a lower risk of developing glioma, but not meningioma or acoustic neuroma. It also supports clinical observations of epilepsy prior to the diagnosis of glioma and meningioma.
COPYRIGHT INFORMATION: (c) 2022. Springer Nature B.V.
LANGUAGE: eng
DATE OF PUBLICATION: 2022 May
DATE OF ELECTRONIC PUBLICATION: 20220203
DATE COMPLETED: 20220622
DATE REVISED: 20250530
MESH DATE: 2022/06/23 06:00
EDAT: 2022/02/05 06:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: 10.1007/s10654-022-00843-y [doi]
OWNER: NLM
Related RSI Experts
Chief Risk Scientist
Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...